abstract |
The present invention relates to compounds encompassed by formula (I), pharmaceutical compositions thereof, methods of inhibiting LTA-4 hydrolase, and methods of treating diseases and disorders ameliorated by inhibition of LTA4-h activity. Non-limiting examples of such diseases and conditions include inflammatory diseases and disorders and autoimmune diseases and disorders. [Selection figure] None |